Page last updated: 2024-08-24

valsartan and allisartan isoproxil

valsartan has been researched along with allisartan isoproxil in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Dong, X; He, X; Wu, J1

Reviews

1 review(s) available for valsartan and allisartan isoproxil

ArticleYear
Cost Effectiveness of the First-in-Class ARNI (Sacubitril/Valsartan) for the Treatment of Essential Hypertension in a Chinese Setting.
    PharmacoEconomics, 2022, Volume: 40, Issue:12

    Topics: Cost-Benefit Analysis; Drug Combinations; Essential Hypertension; Humans; Valsartan

2022